Bliv review
⛔ FDA warning letter #721479 (Feb. 2026), which names joinbliv.com. An explicitly no-video-visit, fully async intake — as low as $116/mo semaglutide, $199/mo tirzepatide — with CareCredit and Klarna pay-later options, though state coverage isn't published.
- Independently scored
- Verified
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
Bliv at a glance
- Semaglutide
- As low as $116/mo
- Tirzepatide
- As low as $199/mo
- Coverage
- Not disclosed — no published state list
- Brand-name
- Compounded only
How we scored Bliv
Each score comes out of Bliv's published pricing, disclosures and oversight, and the six combine into the 63/100 Editors' Rating on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Fair value once you read past any teaser rate or plan structure.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
The headline rate obscures a plan requirement or a hidden step-up.
Workable around a household, though it isn't built around one.
Support is thin once the prescription ships.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
⛔ Added 26 August 2026: Bliv Wellness LLC dba Bliv holds FDA warning letter #721479, dated 20 February 2026. A screen of the WHOLE roster against the live FDA index (3,664 letters, self-test green) turned it up — not a brand-name search — and we confirmed it by reading the letter, which names joinbliv.com. This review had been published for months without mentioning it. A letter discloses; it does not disqualify, and nothing about the ranking changed. $116 and $199, both 'as low as', in a pricing section that never says what a working dose costs. Bliv publishes no state page and no FAQ answer on coverage either — so price and eligibility both get settled on the far side of the form.
What to expect when you sign up
We walked Bliv's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Homepage lists 'as low as $X per month' starting prices for both molecules directly, no intake required to see the numbers
- 2States the intake is 'No Phone Calls. No Video visit' — a fully asynchronous review
- 3Also offers CareCredit (24 months 0%) and Klarna pay-later financing, starting around $29/mo
- 4Claims '30,000+ happy customers' as a trust signal
What we noticed
- Explicitly states no video visit is required — one of the clearer async-intake claims found in this round
- 'As low as' framing means the exact price at a working dose isn't guaranteed by the homepage number
- No state-coverage list found on the pages checked
- No named compounding pharmacy or medical director found on the pages checked
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $116 | Starting priceListed as '*as low as $116 per month' — based on plan structure and eligibility. |
| Compounded tirzepatide | $199 | Starting priceListed as '*as low as $199 per month' — based on plan structure and eligibility. |
Swipe the table to see plan details →
GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from Bliv's public disclosures at last review and change often; confirm the current number on Bliv's own site.
What we like
- Explicitly states no phone call or video visit is required for the intake
- CareCredit (24 months 0%) and Klarna pay-later financing offered, starting around $29/mo
- Claims 30,000+ customers as a trust signal
- Both molecules available with real starting prices
The caveats
- ⛔ FDA warning letter #721479, dated February 20, 2026, to Bliv Wellness LLC dba Bliv, for false or misleading claims and misbranding — the letter names its own site
- Both prices are framed as 'as low as' — the exact cost at a working dose isn't guaranteed
- No state-coverage list published on the pages checked
- No named compounding pharmacy or medical director found on the pages checked
- No brand-name (FDA-approved) option
Bliv for mothers: our verdict
⛔ FDA warning letter #721479 (Feb. 2026), which names joinbliv.com. An explicitly no-video-visit, fully async intake — as low as $116/mo semaglutide, $199/mo tirzepatide — with CareCredit and Klarna pay-later options, though state coverage isn't published. It runs about $116/month — toward the affordable end of what we track.
We weigh Bliv the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the things a generic roundup never gets to.
What Bliv actually costs
- Compounded semaglutide — Starting price: $116/mo
- Compounded tirzepatide — Starting price: $199/mo
That sits below the roughly $179 median ongoing price across the providers we track for mothers — a real cost advantage.
The medications Bliv prescribes
Bliv prescribes semaglutide and tirzepatide — the pair with the strongest evidence behind them, and having both under one account matters when insulin resistance, familiar from PCOS and gestational diabetes, makes tirzepatide the better fit. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Bliv fits — and where it doesn't — for mothers
Worth it if…
- the real monthly cost is a real barrier and you want a low, predictable number.
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Give it a miss if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- a clean regulatory record is a dealbreaker — note the FDA warning flagged in the cons above.
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. It carries an FDA warning letter, flagged in the cons — read it before starting. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
One line that applies to every provider on this masthead: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Bliv is a genuine value play — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Mothers who specifically want to avoid a scheduled video call and are comfortable confirming their state eligibility and real working-dose price at intake.
Alternatives to Bliv
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing Bliv
Head-to-head & alternatives
Bliv, answered
- How much does Bliv cost?
- When we last checked, the cheapest ongoing compounded price at Bliv was around $116 a month: As low as $116/mo for semaglutide and As low as $199/mo for tirzepatide. Prices here move quickly — confirm today's all-in number on their own site before signing up.
- Is Bliv safe to use while breastfeeding?
- No GLP-1 has been shown to be safe in pregnancy or while nursing, whether compounded or brand-name, and the labeling advises against it. That applies to Bliv as much as to anyone else. Time it for after weaning, and make the decision with your own clinician.
- Does Bliv offer both semaglutide and tirzepatide?
- Yes — Bliv offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does Bliv rank for mothers?
- Bliv takes 63/100 in our Editors' Rating, placing it #81. Six factors chosen for mothers feed that number, and CoreAge Rx is the one at the top of the list — see how they compare.
Pricing, states and verification reflect Bliv's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.